AEM vs BTG

AEM's deterministic health score is concerning with a Piotroski F-Score of 4/9, indicating marginal financial stability, while the absence of an Altman Z-Score limits distress risk assessment. Despite strong profitability metrics—ROE of 15.67%, gross margin of 70.24%, and robust earnings growth of 85.8% YoY—the stock trades at a premium valuation (P/E 31.23 vs sector avg 25.89) above both the Graham Number ($85.07) and intrinsic value estimate ($202.66). Strong recent price performance (+145% 1Y) and analyst buy recommendation are counterbalanced by weak technical trend (10/100) and limited insider sentiment (40/100). The balance between operational strength and valuation concerns leads to a neutral stance.

B2Gold Corp. presents a conflicting profile with a stable Piotroski F-Score of 4/9 and a very low forward P/E of 4.22, yet it trades at a premium to its Graham Number ($4.11) and Intrinsic Value ($1.96). While revenue growth is explosive at 110.9%, the company has a dismal earnings track record, missing estimates in all of the last four quarters with an average surprise of -48.34%. The balance sheet is characterized by low leverage (Debt/Equity 0.16) but concerningly low immediate liquidity (Quick Ratio 0.44). Overall, the stock appears to be a value play with significant execution risk and bearish technical momentum.